ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Senate Bill Gives NIH $23.7 Billion, NCI $4.25 Billion, Better Than House.

November 2, 2001

PHS Plans Revitalization of Commissioned Corps

July 11, 2003

ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention

November 16, 1979

Postdoc Fabricated Results In Published Study, ORI Says.

October 27, 2000

In Brief: Angel Bradley To Head NCAB Subcommittee UCLA, USC Join In CCRU Grant Application

September 3, 1982

825,000 Pounds of Yew Bark Clleced in ’91 For 10,000 Patients

March 13, 1992